Dome - For all he did
For all he did
Date: June 15, 2012
In acknowledging Edward D. Miller’s efforts on Capitol Hill to make health care “a right and not a privilege,” U.S. Senator Ben Cardin was among a roster of distinguished speakers who celebrated the leadership of Hopkins’ retiring dean/CEO at a daylong conference held in his honor on June 11.
Tackling the topic, “Moving Academic Medicine Forward,” the conference featured a keynote address by Kathleen Sibelius, secretary of the U.S. Department of Health and Human Services. In her remarks, Sibelius sounded many of the same themes discussed by a lineup of policy experts, researchers and public officials who outlined strategies for the growth of sound medicine and accessible health care.
Whether discussing research trends, electronic health records or health care reform, each speaker’s remarks underscored Miller’s far-sighted leadership in preparing Hopkins and the nation’s health care system for daunting challenges ahead.
Hopkins “is a terrific place to be when talking about the future of medicine,” Sibelius said, noting the institution’s stamp on modern medicine. Because of advances in medicine and care delivery accomplished under Miller’s watch, Hopkins is also the right place “to look around the country and see how far we have to go,” she said.
Miller’s insistence on a strong primary care foundation, sound business model and other strategies, has “left a legacy that will serve Hopkins well in the future,” noted former Bloomberg School of Public Health faculty member Karen Davis, who is now president of the Commonwealth Fund, a foundation devoted to health and social policy research.
At recent farewell events, Hopkins leaders, faculty and staff have paid tribute to Miller for his commitment to patient safety, diversity, gender equity and campus redevelopment. With the new clinical towers, the installation of Epic and a thriving regional primary care network, he’s leaving the enterprise “with a good platform for the future,” said Miller during a conference break.
Yet, a daunting challenge lies ahead, he said: Where to find funding for research aimed at solving chronic diseases such as diabetes and hypertension is “a big question.”